Bonum Therapeutics CEO named Top Industry Leader of 2023 by PharmaVoice 100

John Mulligan, CEO and founder of Seattle-based Bonum Therapeutics was named a Top Industry Leader in PharmaVoice 100’s 2023 Entrepreneurs ranking.

PharmaVoice 100 celebrates the life sciences industry, recognizing nominees who foster change, seek innovation and leave lasting effects on their communities.

Mulligan is a veteran of the life sciences, starting his first biotech company – Blue Heron Biotech – in 1999. He now owns and oversees Bonum Therapeutics, which he launched in Seattle in 2022.

READ THE STORY at PharmaVoice »